Peramivir Use for Treatment of Hospitalized Patients With Influenza A(H1N1)pdm09 Under Emergency Use Authorization, October 2009-June 2010

Yan Yu(Xi'an Jiaotong University), TM Uyeki(National Center for Immunization and Respiratory Diseases), Shikha Garg(Department of Human Services), Patricia Yu(Centers for Disease Control and Prevention), Han‐Joon Kim(Seoul National University Hospital), Tracy Merlin(National Center for Emerging and Zoonotic Infectious Diseases), Susan B. Redd(Centers for Disease Control and Prevention), Anita Patel(University of Maryland, Baltimore)
Clinical Infectious Diseases
April 5, 2012
10.1093/cid/cis352
Cited by 41

Related Papers

Effect of Salt Substitution on Cardiovascular Events and Death
|New England Journal of Medicine|2021|726
Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic — United States, 2020–2021
|MMWR Morbidity and Mortality Weekly Report|2021|611
Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness
|Influenza and Other Respiratory Viruses|2018|327
Surveillance for waterborne disease and outbreaks associated with recreational water use and other aquatic facility-associated health events--United States, 2005-2006.
|PubMed|2008|294
Monkeypox in a Traveler Returning from Nigeria — Dallas, Texas, July 2021
|MMWR Morbidity and Mortality Weekly Report|2022|277